The Mycoses
Most clinical microbiology labs will not routinely identify Cryptococcus isolates to the species level. Although cultures may take up to a week to become positive, Cryptococcus spp. grow on most clinical media, including standard radiometric blood culturing systems. However, in the diagnosis of pulmonary disease, both the sensitivity and specificity of cultures of respiratory secretions are questionable.As previously described, imaging of the chest by plain radiograph and CT is not diagnostic. Isolated or multiple nodules, pulmonary masses, lobar consolidation, cavitary lesions, pleural effusion, diffuse interstitial infiltrates, and adult respiratory distress–like appearance have all been described with pulmonary cryptococcosis. If signs of increased intracranial pressure or other signs suggestive of CNS infection are present, magnetic resonance imaging or CT of the head to rule out hydrocephalus and cryptococcomas is indicated.Given the limitations of noninvasive methods, invasive procedures are often necessary to confirm the diagnosis of Cryptococcus’s, especially when involvement is limited to the lungs. Either fine-needle aspiration or biopsy may be required to confirm the diagnosis. When pleural effusions are present, cultures of thoracentesis fluid are positive in about 40% of AIDS patients
Related Conference of The Mycoses
21st International Conference on Virology, Emerging Diseases & vaccines
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Antimicrobial and Antibacterial Agents
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
The Mycoses Conference Speakers
Recommended Sessions
- Laboratory Diagnosis of Infectious Diseases
- Antimicrobial resistance
- Antimicrobials and Chemotherapy
- Automation
- Bioinformatics in Clinical Microbiology:
- Challenges in Clinical Microbiology Testing
- Chronic Diseases
- Clinical Microbiology and Antimicrobial, Chemotherapy
- Disease, Diagnosis and Prevention
- Emerging Technologies for the Diagnosis of Microbial Infections
- Fungal infections
- Host Pathogen Interaction
- Immunity and Vaccination
- Infection Control and Hospital Epidemiology
- Microbial biochemistry
- Microbial Biofilms
- Microbial Identification by MALDI -TOF MS
- Microbial Infections
- Microbial Pathogenesis
- Microbiological Diagnosis of Lung Infection
- Pathogens and microorganisms
- The Mycoses
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical and Neuro Virology - Virology-2026 (UK)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Emerging infectious diseases and the "One Health" concept - Virology-2026 (UK)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2026 (UK)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- General Virology - Virology-2026 (UK)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Immunization and Immunotherapeutics - Virology-2026 (UK)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Influenza and other Respiratory Diseases - Virology-2026 (UK)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Measles as re-emerging infectious disease - Virology-2026 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- New and Endogenous Retroviruses - Virology-2026 (UK)
- Novel Antiviral Therapies - Virology-2026 (UK)
- Novel Vaccine Delivery Methods - Virology-2026 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- STD's and Non-Viral STIs - Virology-2026 (UK)
- Structural and Molecular virology - Virology-2026 (UK)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
- Transmission of Viruses - Virology-2026 (UK)
- Transplant-Associated Viral Infections - Virology-2026 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2026 (UK)
- Vaccines against tropical and neglected diseases - Virology-2026 (UK)
- Vaccines and the Microbiome - Virology-2026 (UK)
- Veterinary virology - Virology-2026 (UK)
- Viral Genetics, Evolution and Dynamics - Virology-2026 (UK)
- Viral Immunology and Immunopathology - Virology-2026 (UK)
- Viral Oncology - Virology-2026 (UK)
- Viral Pathogenesis - Virology-2026 (UK)

